Global Team. World-Class Results.

Our mission is to improve patient access to medical care through evidence, worldwide

Pharmerit was founded in 2000 in Rotterdam, NL, to foster creative collaboration among researchers dedicated to uncovering and communicating the value of healthcare innovations. This spirit continued to drive us as we expanded our presence across the United States, Europe, and Asia. Through this time, we have benefited from a consistent vision under the same ownership and management.

This shared vision has led to the completion of thousands of projects, hundreds of publications, methodological advances, and a tangible and lasting impact on the healthcare landscape and the fields of epidemiology, HEOR, and market access.

View Publications

Why choose Pharmerit?

Scientific Creativity and Leadership

We have led the evolution of HEOR  by developing and applying innovative solutions to new and old problems


With offices worldwide and colleagues from multicultural backgrounds, we bring a truly international perspective to our discipline

Integrated Experience

Our cross-functional and multidisciplinary teams understand how to integrate the different facets of HEOR and market access to deliver meaningful results


Each Center of Excellence is dedicated to applying the highest scientific standards to our research

and Practical

We approach each project as a unique challenge requiring a customized solution in the spirit of flexible partnership with our sponsors

Dedicated to HEOR and Market Access

We are a team of 130 researchers dedicated to HEOR and strategic market access around the globe


Our Locations

We have locations in three continents allowing us to work alongside global clients from the United States and Europe to Asia.

Pharmerit Global Locations
We help define, build, and communicate your product’s clinical, humanistic, and economic value through 4 Centers of Excellence
Modeling & Meta-Analysis

Modeling & Meta-Analysis

Developing tools to inform policy decision-makers about the clinical and health-economic consequences of health technologies

Patient-Centered Outcomes

Patient-Centered Outcomes

Including the patient perspective to better understand their needs, design better studies, and assess how they value different therapies

Real-World Evidence


Informing decision-making with evidence from “real-world” practice

Strategic Market Access

Strategic Market Access

Communicating the evidence regarding unmet needs and the benefits and costs of treatment innovation to ensure market access and reimbursement

Partner with Pharmerit

Partner with Pharmerit

Contact Us